ERBB2 and breast carcinoma: HER2 is well known for its ability to enhance cell proliferation, survival, motility, and adhesion.[31] HER2 over-expression induces lymphangiogenesis, promotes metastasis, and results in poor prognosis of breast cancer by up-regulating vascular endothelial growth factor-C (VEGF-C) expression.[32]